Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001367644-25-000078
Filing Date
2025-03-21
Accepted
2025-03-21 16:33:53
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A emergentbiosolutionsincn.htm DEFA14A 3516
2 emergentbiosolutionsincn001.jpg GRAPHIC 156779
3 emergentbiosolutionsincn002.jpg GRAPHIC 109863
  Complete submission text file 0001367644-25-000078.txt   371933
Mailing Address 300 PROFESSIONAL DR GAITHERSBURG MD 20879
Business Address 300 PROFESSIONAL DR GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33137 | Film No.: 25761015
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)